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Abstract 
Investigations on "nonclassic" regulators of angiogenesis could open new perspectives in 
understanding  angiogenesis  under  physiological  and  pathological  conditions.  A  pro-
angiogenic effect has been demonstrated for adrenomedullin (AM), it´s co-factor activity-
modifying protein 2 (RAMP-2) and the calcitonin receptor-like receptor (CALCLR). This 
signalling pathway is besides associated with lymphangiogenesis, that (in a physiologically 
way) is still only poorly understood in ovary and its structures. The aim of this study was 
therefore to evaluate mRNA expression of AM, RAMP-2 and CALCLR in bovine corpora 
lutea (CL) during different physiological stages. Experiment 1: CL were assigned days 1-2, 
3-4, 5-7, 8-12, 13-16, >18 (after regression) of oestrous cycle and of gravidity (month <3, 3-
5, 6-7 and >8). Experiment 2: Induced luteolysis. Cows on days 8-12 were injected with a 
PGF2￿ analogue and CL were collected by transvaginal ovariectomy before and 0.5, 2, 4, 
12, 24, 48 and 64 h after PGF2￿ injection. Tissue levels of mRNA were characterized by 
qPCR. All 3 factors were clearly expressed. AM and CALCRL showed significant changes 
in both experiments, RAMP-2 during induced luteolysis. For AM highest levels could be 
observed in the beginning and the end of the luteal phase, CALCRL remained at around the 
same levels. Both factors showed their most expression at the end of pregnancy. During 
induced luteolysis all factors started to decline not until structural luteolysis. In conclusion, 
our  results  could  lead  to  the  assumption  that  factors  investigated  may  be  involved  in 
mechanisms regulating CL formation, function and regression – and a special impact in the 
final month of pregnancy. 
Keywords:  corpus  luteum  function,  lymphangiogenesis,  bovine  oestrous  cycle, 
bovine pregnancy. 
1.Introduction 
Angiogenesis,  the  process  through 
which  new  blood  vessels  arise  from  pre-
existing  ones,  is  regulated  by  several 
"classic"  factors,  among  which  the  most 
studied are vascular endothelial growth factor 
(VEGF)  [1],  [2],  [3].  In  recent  years, 
investigations showed that, in addition to the 
classic  factors,  numerous  endogenous 
peptides  play  a  relevant  regulatory  role  in 
ovary  angiogenesis  [4],  [5],  [6].  Such 
regulatory  peptides,  each  of  which  exerts 
well-known specific biological activities, are 
present,  along  with  their  receptors,  in  the 
blood  vessels  and  may  take  part  in  the Schilffarth and Berisha 
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control  of  the  "angiogenic  switch".  An  in 
vivo  and  in  vitro  pro-angiogenic  effect  has 
been demonstrated for adrenomedullin (AM). 
AM  raises  the  expression  of  VEGF  in 
endothelial  cells,  but  VEGF  blockade  does 
not affect the pro-angiogenic action of AM 
[7]. AM is a ubiquitously expressed 52 amino 
acid peptide that is a member of the family of 
calcitonin  gene–related  peptides  (CGRPs) 
and  was  initially  isolated  from 
phaechromyctoma  in  1933  [23].  It  was 
initially  demonstrated  to  have  profound 
effects  in  vascular  cell  biology,  since  AM 
protects  endothelial  cells  from  apoptosis, 
promotes  angiogenesis  and  affects  vascular 
tone and permeability [8]. Receptor activity–
modifying  proteins  (RAMPs),  single  pass 
transmembrane  proteins  that  associate  with 
GPCRs  modulate  the  ligand  binding  of  the 
calcitonin receptor–like receptor (CALCRL) 
such  that  RAMP1-CALCRL  functions 
primarily as a CGRP receptor and RAMP2/3-
CALCRL  functions  primarily  as  an  AM 
receptor [9]. The AM signalling pathway is 
besides  associated  with  lymphangiogenesis, 
that (in a physiologically way) is still only 
poorly understood in ovary and its structures. 
In contrast to angiogenesis and its involved 
factors  that  have  been  investigated 
intensively for the last decade, no attention to 
lymphangiogenesis  has  been  paid  until 
recently [10] [11]. Studies by [12] and [21] 
demonstrated  that  loss  of  signalling  by  the 
AM results in embryonic oedema and death. 
Remarkably,  this  phenotype  is  attributed  to 
defects  in  lymphatic  vessels  by  one  group 
and to defects in blood vessels by the other 
[22].  The  objective  of  this  study  was  the 
characterization  of  AM,  RAMP-2  and 
CALCLR  mRNA  expression  in  the  bovine 
CL. Since blood vessel growth is known to 
be essential for CL development, maturation 
and function, it is of much interest to find out 
if these “nonclassic” factors are involved in 
this context.  
2. Material and Methods 
Experiment  1:  Collection  of  bovine  CL 
during oestrous cycle and pregnancy 
The  bovine  CL  were  collected  at  the 
local slaughterhouse within 10-20 min after 
slaughter.  The  stage  of  oestrous  cycle  was 
determined  by  examining  macroscopically 
the  size,  colour,  consistency,  connective 
tissue and mucus of the ovaries and uteri as 
previously described [2]. CL were assigned 
to the stages days 1-2, 3-4, 5-7, 8-12, 13-16, 
>18 (after regression) of oestrous cycle and 
of  pregnancy  month  1-2,  3-4,  6-7,  >8  (the 
crown-rump  length  of  the  foetus  was 
measured  to  evaluate  the  month  of 
pregnancy)  (n=6-7/group  from  different 
animals). Luteal tissue was frozen in liquid 
nitrogen  and  stored  at  -80°C  until  RNA 
extraction. 
Experiment  2:  Collection  of  bovine  CL 
during induced luteolysis 
Cows  (Holstein  Frisians  and  Brown 
Swiss) at mid-luteal phase
 (days 8–12) were 
injected  i.m.  with  500  µg  PGF2￿  analogue 
Cloprostenol  (Estrumate
®,  Intervet, Adrenomedullin signalling in bovine CL 
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Germany).  The  CL
  were  collected  by 
transvaginal ovariectomy 0.5, 2, 4, 12, 24,
 48 
and  64  h  (n=5/group  from  5  different 
animals) after PGF2￿ injection. Control CL 
(0 h) were collected from a local slaughter 
house (previously described by [4]. 
Total  RNA  extraction  and  reverse 
transcription 
Constant amounts of 1 ￿g of total RNA 
were reverse transcribed to cDNA using the 
following  master  mix:  26  ￿l  Rnase-free 
water, 12 ￿l 5x Buffer (Promega, Mannheim, 
Germany),  3  ￿l  Random  Primers  (50  mM) 
(Invitrogen™,  Carlsbad,  Germany),  3  ￿l 
dNTPs  (10  mM)  (Fermentas,  St.  Leon-Rot, 
Germany)  and  200  U  of  MMLV  Reverse 
Transcriptase  (Promega,  Mannheim, 
Germany)  according  to  the  manufacturer’s 
instructions as previously described [1] 
Quality determination of total RNA 
Degradation of the RNA was measured 
with  the  Agilent  2100  bioanalyzer  (Agilent 
Technologies,  Deutschland  Gmbh, 
Waldbronn,  Germany)  in  conjunction  with 
the RNA 6000 Nano Assay, according to the 
manufacturer' s instructions. The bioanalyzer 
enables  the  standardization  of  RNA  quality 
control. RNA samples are electrophoretically 
separated  on  a  microfabricated  chip,  and 
subsequently  detected  with  laser-induced 
fluorescence  induction.  The  Bioanalyzer 
electropherogram  of  total  RNA  shows  two 
distinct  ribosomal  peaks  corresponding  to 
either 18S or 28S for eukaryotic RNA, and a 
relatively  flat  baseline  between  the  5S  and 
18S  ribosomal  peaks.  The  automatically 
calculated  RNA  integrity  number  (RIN) 
allows classification of total RNA based on a 
numbering system from 1 to 10, with 1 being 
the most degraded profile and 10 being the 
most intact [13] 
Real-Time PCR quantification 
A master mix of the following reaction 
components was prepared: 6.4 ￿l water, 1.2 
￿l MgCl2 (4 mM), 0.2 ￿l forward primer (0.2 
mM),  0.2  ￿l  reverse  primer  (0.2  mM),  and 
1.0 ￿l LightCycler® Fast Start DNA Master 
SYBR  Green  I  (Roche  Diagnostics, 
Mannheim, Germany). The master mix (9 ￿l) 
was added to the strip tubes and 1 ￿l PCR 
template  containing  16.66  ng  reverse 
transcribed  total  RNA  was  added.  The 
following  general  real-time  PCR  protocol 
was  employed  for  all  investigated  factors: 
denaturation for 10 min at 95°C, 40 cycles of 
a  three  segmented  amplification  and 
quantification  program  (denaturation  for  10 
sec  at  95°C,  annealing  for  10  sec  at  the 
primer  specific  temperature,  elongation  for 
15  sec  at  72°C),  a  melting  step  by  slow 
heating  from  60  to  99°C  with  a  rate  of 
0.58°C/sec  and  continuous  fluorescence 
measurement,  and  a  final  cooling  down  to 
40°C.  Crossing  point  (cp)  values  were 
acquired  by  using  the  second  derivative 
maximum  method  of  the  Rotor-Gene  6 
software  (Corbett  Research,  Mortlake, 
Australia). Real-time PCR efficiencies were 
determined  by  amplification  of  a 
standardized dilution series, and slopes were Schilffarth and Berisha 
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calculated  using  Rotor-Gene  6  software 
(Corbett Research, Mortlake, Australia). The 
specificity of the desired products in bovine 
CL was documented using a high resolution 
gel  electrophoresis  and  analysis  of  the 
melting  temperature,  which  is  product 
specific. 
Primers 
For primer design the HUSAR
® (DKFZ) 
software was used. The primers used for real-
time PCR were as follows: histone (232bp) 
forward 5’-ACT GCT ACA AAA GCC GCT 
C-3’  and  reverse  5’-ACT  GCC  TCC  TGC 
AAA  GCAC-3’.  [14],  Adrenomedullin 
(190bp)  forward  5’-  CCA  GAC  TCT  TAT 
TCG GCC C -3’ and reverse 5’- GAA ATG 
GTA  GAT  CTG  ATG  CGC  -3’ 
(NM_173888),  RAMP-2  forward  5’-CCA 
AGT  CAG  AAG  GGA  AAA  CG-3’  and 
reverse 5’- CAA AGA TGA TCT CTT CCG 
CC -3’ (NM_001098860) and calcrl forward 
5’- TCC CAG TTC ATC CAT CTC TAC C-
3’  and  reverse  5’-  TCT  GGC  AAC  AGC 
GTG AAT AC -3’ (NM_001102107). 
Statistical analysis 
The  statistical  significance  of 
differences  in  mRNA  expressions  of  the 
examined  factors  was  assessed  by  one-way 
ANOVA  followed  by  the  Holm-Sidak  as  a 
multiple  comparison  test.  Differences  were 
considered  significant  if  P<0.05.  All 
experimental data are shown as 40 minus the 
mean of (normalized) Dcp ± SEM (standard 
error  of  the  mean),  so  that  a  high  “40-cp” 
value indicated a high gene expression level 
and vice versa. 
3. Results 
RNA Quality Determination 
RIN values of the used samples ranged 
between  7.1  and  9.2.  All  samples  revealed 
two distinct ribosomal peaks, corresponding 
to 18S and 28S for eukaryotic RNA. 
Confirmation  of  Primer  Specificity  and 
Sequence Analysis 
The mRNA expression was analyzed by 
real-time  reverse  transcription  PCR  (RT-
PCR) with the Rotor-Gene 3000. Initial RT-
PCR experiments verified specific transcripts 
for all factors in bovine CL. For exact length 
verification,  RT-PCR  products  were 
separated on 2% high-resolution agarose gel 
electrophoresis. PCR products were verified 
by  commercial  DNA  sequencing  (TopLab, 
Munich,  Germany).  Each  PCR  product 
showed 100% homology to the known genes 
after sequencing. 
Housekeeping Gene Expression 
To evaluate equal quantity and quality 
of  the  preceding  reverse  transcription 
reaction  in  each  sample,  the  housekeeping 
genes, ubiquitin and histone, were examined 
in all samples. As both housekeeping genes 
were constantly expressed in all samples, we 
chose histone as normaliser. The results of 
mRNA  expression  of  the  examined  factors 
are presented as changes (40 − ￿CP ± SEM Adrenomedullin signalling in bovine CL 
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from  5  CL  per  group)  in  the  target  gene 
expression, normalized to Histon. 
 
 
 
  
 
 
 
Figure 1. Expression of mRNA of (A) Adrenomedullin, (B) CALCLR and (C) CALCLR 
in the CL of oestrous cycle and gravidity. Results are presented by 40 minus mean of 
normalized  crossing  points  (Dcp)  ±  SEM  (n=6-7).  Different  superscripts  denote 
statistically different values (P<0.05). 
1A 
1B 
1C Schilffarth and Berisha 
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Figure 2. Expression of mRNA of (A) Adrenomedullin, (B) RAMP-2 and (C) CALCLR in 
the CL during induced luteolysis. Results are presented by 40 minus mean of normalized 
crossing  points  (Dcp)  ±  SEM  (n=6-7).  Different  superscripts  denote  statistically  different 
values (P<0.05). 
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Expression of AM, RAMP-2 and CALCLR in 
CL during oestrous cycle and gravidity 
As shown in fig. 1A mRNA expression 
of AM starts highly in the beginning of the 
luteal  phase  and  decreases  significantly  on 
days  3-4  and  5-7.  Midluteal  the  expression 
rises again and reaches levels from the start 
during  regression.  For  RAMP-2  no 
significant  changes  of  mRNA  expression 
could  be  obtained.  Expression  performance 
of the receptor CALCLR is shown in fig. 1B. 
Here the highest levels are midluteal on days 
8-12 but those in the beginning and the end 
are  similar  again.  Both  factors  have  their 
peak at the end of pregnancy in month >8. 
Expression of AM, RAMP-2 and CALCLR in 
CL during induced luteolysis 
In CL during induced luteolysis mRNA 
expression of AM and RAMP-1 not changes 
significantly  until  24  h  (AM)  and  48  h 
(RAMP-2) after PGF2￿. AM and CALCLR 
levels drop down significantly after 48 h the 
one  of  RAMP-2  not  until  64  h  after 
induction. 
4. Discussion 
AM
  signalling  is  of  particular 
significance in endothelial cell
 biology since 
the  peptide  protects  cells  from  apoptosis, 
promotes
 angiogenesis,  and  affects  vascular 
tone  and  permeability  [15].  That 
angiogenesis  in  the  reproductive  tract  and 
especially in the ovary is of great importance 
for  its  accurate  function  is  nowadays  well 
established [16][24], [1, 2, 17]. What is more 
AM  is  demanding  in  various  tumours  [25] 
and  when  cardiovascular  problems  occur 
[18]. Whether in pathologic circumstances or 
physiologically, hypoxia is a key stimulus for 
angiogenesis.  Hypoxia-inducible  factor  1 
(HIF-1)  is  the  master  regulator  of  oxygen 
homeostasis  [19]  Low  oxygen  levels  and 
therefore  HIF-1￿  effects  do  not  only  up 
regulate the expression of VEGF, endothelin-
1 and -2 und angiogenin but also the one of 
AM  [8].  Its  receptor  CALCLR  is  also  up 
regulated under hypoxic conditions in micro 
vascular  endothelial  cells  (EC),  whereas 
RAMP-2 in EC is not activated by a lack of 
oxygen [20]. Our results during regression of 
CL  (>18  day  of  cycle)  conform  to  these 
findings.  When  the  CL  undergoes 
degeneration  unavoidable  hypoxia  comes 
into being. Thus HIF-1￿ is up regulated, that 
in  turn  activates  AM  and  CALCLR 
expression  [8].  High  mRNA  expression  in 
the  beginning  of  luteal  phase  is  due  to  the 
enormous angiogenic rate needed during CL 
formation [2]. The high levels at the end of 
pregnancy could also be in agreement with 
this theory, as well as the fact that expression 
of  all  three  factors  starts  to  decline 
significantly very late (48 or even 64 h after 
PGF2￿).  Hypoxia  activates  AM  and  its 
receptor. Maybe they act in a kind of survival 
strategy for the cells that undergo regression. 
RAMP-2  follows.  As  recently  as  structural 
luteolysis is in full activity its mRNA levels 
decline.  Schilffarth and Berisha 
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